Medindia LOGIN REGISTER
Medindia
Advertisement

FDA Approves REBEL Bare-metal Stent

by Sheela Philomena on July 24, 2014 at 10:21 AM
 FDA Approves REBEL Bare-metal Stent

Boston Scientific Corporation has announced that it has received FDA approval for the REBEL™ Platinum Chromium Coronary Stent System. This is company's latest generation bare-metal stent for the treatment of coronary artery disease (CAD). Bare-metal stents continue to play an important role in the treatment of CAD and represent a significant portion of the global stent market.  The company announced CE Mark for the Rebel Stent System in February.

The REBEL Stent System expands the Boston Scientific family of stents featuring its proprietary platinum chromium (PtCr) alloy and a customized stent architecture design.  The REBEL Stent offers the identical stent platform as the Promus PREMIER™ Drug-Eluting Stent (DES) but without the Everolimus drug.

Advertisement

"Bare-metal stents are an important part of our practice, as not every patient can receive a drug-eluting stent.  This new bare-metal stent has the same great visibility and deliverability as the PREMIER DES but allows me to treat patients who are not candidates for DES therapy," said John C. Wang, M.D., of Medstar Union Memorial Hospital, Baltimore, Md. "In addition, the platinum chromium architecture provides great radial strength with low recoil, which is particularly important in patients receiving bare-metal stents."

The REBEL Stent System features unparalleled visibility, low recoil, exceptional radial strength and fracture resistance, while improving axial strength and deliverability.  Its enhanced low-profile delivery system also features a shorter, more visible tip, a dual-layer balloon and a Bi-Segment™ inner lumen catheter designed to facilitate precise stent delivery across challenging lesions.
Advertisement

"Boston Scientific is committed to developing the best treatment options for all patients with coronary artery disease," said Kevin Ballinger, president, Interventional Cardiology, Boston Scientific. "Launching the Rebel Stent System in the U.S. is another important step to ensure that we offer physicians the most differentiated and broadest product portfolio possible."

Of note, Dr. Wang presented data from the OMEGA clinical trial evaluating the REBEL Stent System in February at the Cardiovascular Research Technologies conference in Washington, D.C.  OMEGA is a single arm, multi-center trial in the U.S. and Europe and the first reported results showed low event rates at nine months.

The REBEL Stent System is offered in a matrix of 46 sizes, ranging in diameter from 2.25 mm to 4.50 mm and lengths of 8 mm to 32 mm on a Monorail™ platform.  This provides physicians with a range of options designed to best suit patient needs.

Source: Medindia
Font : A-A+

Advertisement

Advertisement
Advertisement

Latest Medical Gadgets

Sonic Vision Aids Blind Individuals in Deciphering Basic Faces
Blind individuals utilize the specific area in the brain to recognize basic faces, a function vital for sighted face processing.
New Migraine Management Wearable Introduced
Nerivio, the first-of-its-kind product for migraine in India, holds USFDA approval, is drug-free, noninvasive, and exhibits a promising safety profile.
Medical Wearable Tech Hits $100 Billion in 2023
Health-sensing wearables revolutionize healthcare, empowering control. They aid remote patient monitoring, track vital signs like heart rate, glucose, blood pressure.
Ingestible Capsule Detects Sleep Apnea Breathing Issues
The Celero Systems capsule, designed for diagnosing sleep apnea, also holds potential in detecting opioid overdoses among high-risk individuals.
Mini-Wearable Device Captures Body Sounds to Monitor Health
A wearable wireless acoustic device records body's delicate sounds. They are useful for monitoring heart, respiration, and bowel sounds to detect abnormalities.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

FDA Approves REBEL Bare-metal Stent Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests